XML 28 R18.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
STOCKHOLDERS’ EQUITY (Tables)
3 Months Ended
Mar. 31, 2024
Equity [Abstract]  
SCHEDULE OF WARRANT ACTIVITY

A summary of the Company’s warrant activity and related information follows:

  

           Weighted 
       Weighted   Average 
       Average   Remaining 
   Number of   Exercise   Life 
   Warrants   Price   In Years 
Outstanding, January 1, 2024   4,791,019   $10.57      
Granted   2,513,686    2.43      
Exercised   (3,351,580)   2.33      
Expired   (285)   3,211      
Outstanding, March 31, 2024   3,952,840   $4.10    4.1 
                
Exercisable, March 31, 2024   3,952,840   $4.10    4.1 
SCHEDULE OF WARRANT ACTIVITY

A summary of the Company’s warrant activity and related information follows:

  

           Weighted 
       Weighted   Average 
       Average   Remaining 
   Number of   Exercise   Life 
   Warrants   Price   In Years 
Outstanding, January 1, 2024   4,791,019   $10.57      
Granted   2,513,686    2.43      
Exercised   (3,351,580)   2.33      
Expired   (285)   3,211      
Outstanding, March 31, 2024   3,952,840   $4.10    4.1 
                
Exercisable, March 31, 2024   3,952,840   $4.10    4.1 
SCHEDULE OF STOCK OPTION GRANTED ASSUMPTIONS

In applying the Black-Scholes option pricing model to stock options granted, the Company used the following assumptions:

  

   For the Three Months Ended 
   March 31, 
   2024   2023 
Risk free interest rate    4.144.30%   4.22%
Expected term (years)    2.775.27    3.5 
Expected volatility    101 - 102%   175%
Expected dividends    0.00%   0.00%
SCHEDULE OF STOCK OPTION ACTIVITY

A summary of the stock option activity during the three months ended March 31, 2024 is presented below:

 

           Weighted     
       Weighted   Average     
       Average   Remaining     
   Number of   Exercise   Life   Intrinsic 
   Options   Price   In Years   Value 
Outstanding, January 1, 2024   1,466,892   $4.11           
Granted   1,934,716    1.45           
Exercised   -    -                  
Forfeited   -    -           
Outstanding, March 31, 2024   3,401,608   $2.60    8.3   $- 
                     
Exercisable, March 31, 2024   2,028,811   $3.22    7.9   $- 
SCHEDULE OF UNVESTED RESTRICTED STOCK UNITS

A summary of the Company’s unvested RSUs as of March 31, 2024 is as follows:

 

   Number of Shares 
Non-vested at January 1, 2024                        97,827 
Granted   - 
Vested   (97,827)
Forfeited   - 
Non-vested at March 31, 2024   - 
SCHEDULE OF STOCK OPTION EXPENSE

The following table presents information related to stock-based compensation expense:

 

   For the Three Months Ended   Unrecognized at   Weighted Average Remaining 
   March 31,   March 31,   Amortization Period 
   2024   2023   2024   (Years) 
General and administrative  $2,028,374   $3,378,495   $1,668,697                                 2.04 
Total  $2,028,374   $3,378,495   $1,668,697    2.04 
SCHEDULE OF STOCK COMPENSATION BY AWARD TYPE

The following table presents stock-based compensation by award type:

 

SCHEDULE OF STOCK COMPENSATION BY AWARD TYPE

   For the Three Months Ended 
   March 31, 
   2024   2023 
Options  $1,043,336   $2,190,428 
RSUs   985,038    1,188,067 
Total  $2,028,374   $3,378,495